Human immune deficiency virus (HIV) infection and the hypothalamic pituitary adrenal axis (Q38111240)

29 August 2017

Human immune deficiency virus (HIV) infection and the hypothalamic pituitary adrenal axis (English)

1 reference

29 August 2017

Minu M George

1

1 reference

PubMed ID

23728720

29 August 2017

Amrit Bhangoo

series ordinal

2

1 reference

29 August 2017

1 June 2013

1 reference

Reviews in Endocrine and Metabolic Disorders

29 August 2017

1 reference

29 August 2017

14

1 reference

29 August 2017

105-112

1 reference

29 August 2017

2

1 reference

https://scigraph.springernature.com/pub.10.1007/s11154-013-9244-x

29 August 2017

0 references

cites work

HIV disease and the endocrine system

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9244-X

Adrenal insufficiency in HIV infection: a review and recommendations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9244-X

Low dose adrenocorticotropic hormone test and adrenal insufficiency in critically ill acquired immunodeficiency syndrome patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9244-X

The hypothalamic-pituitary-adrenal axis and immune-mediated inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9244-X

The concepts of stress and stress system disorders. Overview of physical and behavioral homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9244-X

Characterization of a 41-Residue Ovine Hypothalamic Peptide That Stimulates Secretion of Corticotropin and β-Endorphin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9244-X

Folding of the glucocorticoid receptor by the heat shock protein (hsp) 90-based chaperone machinery. The role of p23 is to stabilize receptor.hsp90 heterocomplexes formed by hsp90.p60.hsp70.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9244-X

Folding of the glucocorticoid receptor by the reconstituted Hsp90-based chaperone machinery. The initial hsp90.p60.hsp70-dependent step is sufficient for creating the steroid binding conformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9244-X

Steroid receptor interactions with heat shock protein and immunophilin chaperones

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9244-X

A new first step in activation of steroid receptors: hormone-induced switching of FKBP51 and FKBP52 immunophilins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9244-X

FK506-binding proteins 51 and 52 differentially regulate dynein interaction and nuclear translocation of the glucocorticoid receptor in mammalian cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9244-X

Hormone-mediated repression: a negative glucocorticoid response element from the bovine prolactin gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9244-X

Glucocorticoid receptor binding to a specific DNA sequence is required for hormone-dependent repression of pro-opiomelanocortin gene transcription

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9244-X

Physical association and functional antagonism between the p65 subunit of transcription factor NF-kappa B and the glucocorticoid receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9244-X

Functional interactions between Stat5 and the glucocorticoid receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9244-X

Glucocorticoids act within minutes to inhibit recruitment of signalling factors to activated EGF receptors through a receptor-dependent, transcription-independent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9244-X

Tissue-specific glucocorticoid action: a family affair

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9244-X

Acquired Immune Deficiency Syndrome: Postmortem Findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9244-X

Seroprevalence of cytomegalovirus infection in the United States, 1988-1994

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9244-X

Cytomegalovirus (CMV) retinitis and CMV antigenemia as a clue to impaired adrenocortical function in patients with AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9244-X

Adrenal pathology in the acquired immune deficiency syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9244-X

Adrenal insufficiency, recurrent bacteremia, and disseminated abscesses caused by Nocardia asteroides in a patient with acquired immunodeficiency syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9244-X

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9244-X

Kaposi's sarcoma. Epidemiology, pathogenesis, histology, clinical spectrum, staging criteria and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9244-X

Towards a unified model of neuroendocrine-immune interaction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9244-X

Cytokines and endocrine function: an interaction between the immune and neuroendocrine systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9244-X

Ghrelin stimulates corticotropin-releasing factor and vasopressin gene expression in rat hypothalamic 4B cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9244-X

Glucocorticoid resistance and the immune function in the immunodeficiency syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9244-X

HIV-1 protein Vpr suppresses IL-12 production from human monocytes by enhancing glucocorticoid action: potential implications of Vpr coactivator activity for the innate and cellular immunity deficits observed in HIV-1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9244-X

Human immunodeficiency virus type-1 accessory protein Vpr: a causative agent of the AIDS-related insulin resistance/lipodystrophy syndrome?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9244-X

The role of Vpr in HIV-1 pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9244-X

Cooperative interaction between HIV-1 regulatory proteins Tat and Vpr modulates transcription of the viral genome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9244-X

The HIV-1 virion-associated protein vpr is a coactivator of the human glucocorticoid receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9244-X

Human immunodeficiency virus glycoprotein (gp120) induction of monocyte arachidonic acid metabolites and interleukin 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9244-X

Central nervous system expression of HIV-1 Gp120 activates the hypothalamic-pituitary-adrenal axis: evidence for involvement of NMDA receptors and nitric oxide synthase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9244-X

HIV-1 Gp120 protein modulates corticotropin releasing factor synthesis and release via the stimulation of its mRNA from the rat hypothalamus in vitro: involvement of inducible nitric oxide synthase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9244-X

Adrenocortical function in acquired immunodeficiency syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9244-X

Endocrine disorders in men infected with human immunodeficiency virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9244-X

Low-dose adrenocorticotropin test in patients with the acquired immunodeficiency syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9244-X

Adrenal suppression and Cushing's syndrome secondary to an interaction between ritonavir and fluticasone: a review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9244-X

Adrenal suppression due to an interaction between ritonavir and injected triamcinolone: a case report

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9244-X

Type 1 and Type 2 Cytokines in HIV Infection – A Possible Role in Apoptosis and Disease Progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-013-9244-X

Adrenal function and the hypothalamo-pituitary adrenal axis in immunodeficiency virus-associated tuberculosis.

21 January 2018

1 reference

12 December 2020

Molecular chaperone interactions with steroid receptors: an update

1 reference

12 December 2020

Primary Addison's Disease in a Patient with the Acquired Immunodeficiency Syndrome

1 reference

12 December 2020

Adrenal Necrosis in the Acquired Immunodeficiency Syndrome

1 reference

12 December 2020

[Primary adrenal failure and AIDS: report of 11 cases and review of the literature]

1 reference

12 December 2020

Autopsy findings in the acquired immune deficiency syndrome

1 reference

12 December 2020

Adrenal insufficiency as a complication of the acquired immunodeficiency syndrome

1 reference

12 December 2020

10.1007/S11154-013-9244-X

Identifiers

DOI

1 reference

PubMed ID

23728720

Dimensions Publication ID

29 August 2017

0 references

1 reference

PubMed ID

23728720